Skip to content
MarketScale
‹ Back to Industries

Sciences

MarketScale Original Series: Welcome to the Show

Nothing says summer in America like our National Pastime. Terence Mann (played by James Earl Jones) may have said it best in the classic baseball movie Field of Dreams: “The one constant through all the years, Ray, has been baseball. America has rolled by like an army of steamrollers. It’s been erased like a blackboard, rebuilt,…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · Featured Videos
Share
MarketScale Original Series: Welcome to the Show

Key takeaways

01

Nothing says summer in America like our National Pastime.

02

Terence Mann (played by James Earl Jones) may have said it best in the classic baseball movie Field of Dreams: “The one constant through all the years, Ray, has been baseball.

03

America has rolled by like an army of steamrollers.

Nothing says summer in America like our National Pastime.

Terence Mann (played by James Earl Jones) may have said it best in the classic baseball movie Field of Dreams:

“The one constant through all the years, Ray, has been baseball. America has rolled by like an army of steamrollers. It’s been erased like a blackboard, rebuilt, and erased again. But baseball has marked the time. This field, this game, is a part of our past, Ray. It reminds us of all that once was good, and that could be again.” 

And while baseball is a part of our past, the game faces challenges. In an accelerating world, a slowing pace of game is losing the attention of younger and older fans alike. If baseball is to retain its crown as the national pastime, it’s going to need new energy and increased engagement with its fans.

Enter the Savannah Bananas.

Owner Jesse Cole is making people fall in love with the game of baseball again one inning at a time with promotions not found anywhere else in the sport, delivering one sell-out after another. Summer nights at the Bananas’ Grayson Stadium are nothing short of magical, with the perfect fusion of good college baseball, and unmatched ‘fans first’ experiences.

But not without the challenges of running the organization, staying creative and for Jesse, delegating responsibility to his new Director of Fun, Tyler Gray.

MarketScale’s original series “Welcome to the Show” goes behind the scenes with the Bananas as they prepare for the 2018 home opener.

Three days before another summer of amateur baseball, the Savannah Bananas roster is just arriving at Grayson Stadium for the first time. Unlike most summer ball teams, the Bananas have different priorities than just shagging fly ball, taking batting practice and impressing scouts on day one. In this organization, it’s all about the show.

In just over 24 hours, the team will welcome 4,000 fans through the turnstiles just to watch practice, or “Fan Fest” as it’s called. First impressions are everything for the Bananas, and Fan Fest is the first impression of the summer for a team that cannot afford to play in front of sparse crowds.

In Tyler Gray’s debut, the team expects its entertainment to be bigger and bolder than ever before. But with a newcomer leading the way, this is easier said than done. Gray is taking the master of ceremonies reigns from Cole who, with a young family, is choosing to step back and delegate minute-by-minute operations to his staff.

Director of First Impressions Keke Coles begins a new season with dozens of new interns and volunteers as well. Few have ever experienced the pressure of putting on an entertaining experience that includes an all-you-can-eat buffet, zany promotions and plenty of chances to interact with the team.

Leading the players is new manager Tyler Gillum, who must not only coach the team to another winning season, but must also adapt to an environment where his roster is required to participate in off-field entertainment during games.

Tune in to Episode One of “Welcome to the Show”, to find out of the new staff can deliver the fan experience Savannah has come to expect with the Bananas, launch the first event of the season, and continue to reinvent the game of baseball.

About the author

S
Sciences

New to MarketScale?

MarketScale is the platform Sciences companies use to turn their own experts into content like this. Want the short overview?

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I clinical study of an oral solid dose formulation designed using AI, cleared by the UK's MHRA and conducted at the company's UK facility. The trial—built on machine learning algorithms from partner Intrepid Labs and Quotient's Translational Pharmaceutics platform—aims to validate AI as a direct contributor to formulation design rather than just an upstream analytical tool. Benchling characterizes the broader moment as biotech entering a "builder phase," in which leading organizations embed AI capability at the bench level rather than running isolated pilots.

  • 01Quotient Sciences has dosed healthy volunteers in a Phase I study it describes as the first clinical evaluation of an AI-designed oral formulation, following approval from the UK's MHRA.
  • 02The formulation was developed using advanced machine learning algorithms from Intrepid Labs, integrated with Quotient Sciences' Translational Pharmaceutics platform.
  • 03Benchling identifies a sector-wide shift toward embedding AI capability directly at the bench, moving beyond isolated pilots to structural adoption across biotech R&D.

Jun 17, 2026

Tekniplex Showcases Sustainable Materials Innovation at Paris Packaging Week 2026

Tekniplex Showcases Sustainable Materials Innovation at Paris Packaging Week 2026

At Paris Packaging Week 2026, Tekniplex showcased its latest sustainable materials innovations, emphasizing the intersection of materials science and brand storytelling. The company's booth featured a living wall and digital displays to engage a sustainability-conscious audience, highlighting advanced materials for sustainability and product performance in cosmetics packaging.

  • 01Tekniplex emphasized sustainable materials innovation at Paris Packaging Week 2026.
  • 02The company's booth featured eco-friendly design elements and immersive digital displays.
  • 03Tekniplex highlighted advancements in recyclable sealing systems and materials for cosmetics.

Apr 9, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences